GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Yamashita Health Care Holdings Inc (TSE:9265) » Definitions » ROE %

Yamashita Health Care Holdings (TSE:9265) ROE % : 0.00% (As of Nov. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Yamashita Health Care Holdings ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Yamashita Health Care Holdings's annualized net income for the quarter that ended in Nov. 2024 was 円0 Mil. Yamashita Health Care Holdings's average Total Stockholders Equity over the quarter that ended in Nov. 2024 was 円8,618 Mil. Therefore, Yamashita Health Care Holdings's annualized ROE % for the quarter that ended in Nov. 2024 was 0.00%.

The historical rank and industry rank for Yamashita Health Care Holdings's ROE % or its related term are showing as below:

TSE:9265' s ROE % Range Over the Past 10 Years
Min: 2.28   Med: 6.91   Max: 9.35
Current: 6.83

During the past 7 years, Yamashita Health Care Holdings's highest ROE % was 9.35%. The lowest was 2.28%. And the median was 6.91%.

TSE:9265's ROE % is ranked worse than
53.27% of 107 companies
in the Medical Distribution industry
Industry Median: 7.14 vs TSE:9265: 6.83

Yamashita Health Care Holdings ROE % Historical Data

The historical data trend for Yamashita Health Care Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yamashita Health Care Holdings ROE % Chart

Yamashita Health Care Holdings Annual Data
Trend May18 May19 May20 May21 May22 May23 May24
ROE %
Get a 7-Day Free Trial 6.91 9.35 8.95 2.76 7.05

Yamashita Health Care Holdings Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Nov24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.17 15.62 -1.82 6.52 -

Competitive Comparison of Yamashita Health Care Holdings's ROE %

For the Medical Distribution subindustry, Yamashita Health Care Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yamashita Health Care Holdings's ROE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Yamashita Health Care Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Yamashita Health Care Holdings's ROE % falls into.



Yamashita Health Care Holdings ROE % Calculation

Yamashita Health Care Holdings's annualized ROE % for the fiscal year that ended in May. 2024 is calculated as

ROE %=Net Income (A: May. 2024 )/( (Total Stockholders Equity (A: May. 2023 )+Total Stockholders Equity (A: May. 2024 ))/ count )
=580/( (7906+8541)/ 2 )
=580/8223.5
=7.05 %

Yamashita Health Care Holdings's annualized ROE % for the quarter that ended in Nov. 2024 is calculated as

ROE %=Net Income (Q: Nov. 2024 )/( (Total Stockholders Equity (Q: May. 2024 )+Total Stockholders Equity (Q: Nov. 2024 ))/ count )
=0/( (8541+8694)/ 2 )
=0/8617.5
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Nov. 2024) net income data. ROE % is displayed in the 30-year financial page.


Yamashita Health Care Holdings  (TSE:9265) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Nov. 2024 )
=Net Income/Total Stockholders Equity
=0/8617.5
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0 / 0)*(0 / 26499.5)*(26499.5 / 8617.5)
=Net Margin %*Asset Turnover*Equity Multiplier
=N/A %*0*3.0751
=ROA %*Equity Multiplier
=N/A %*3.0751
=0.00 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Nov. 2024 )
=Net Income/Total Stockholders Equity
=0/8617.5
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0 / 0) * (0 / 0) * (0 / 0) * (0 / 26499.5) * (26499.5 / 8617.5)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= N/A * N/A * N/A % * 0 * 3.0751
=0.00 %

Note: The net income data used here is four times the quarterly (Nov. 2024) net income data. The Revenue data used here is four times the quarterly (Nov. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Yamashita Health Care Holdings ROE % Related Terms

Thank you for viewing the detailed overview of Yamashita Health Care Holdings's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yamashita Health Care Holdings Business Description

Traded in Other Exchanges
N/A
Address
3-6-15 Watanabedori, Chuo-ku, Fukuoka, JPN, 810-0004
Yamashita Health Care Holdings Inc is a Japan-based medical equipment wholesale company that sells medical equipment for medical institutions within the Kyushu area. The company is also engaged in the manufacture, sale, leasing, and rental of optical instruments, physicochemical instruments, analytical instruments, measuring instruments, health equipment, exercise equipment, nursing care equipment, animal medical equipment, and veterinary drugs.

Yamashita Health Care Holdings Headlines

No Headlines